Abbas S, Abbas B, Amir S, Wajahat M (2021) Evaluation of adverse effects with COVID-19 vaccination in Pakistan. Pak J Med Sci 37:1959–1964

Article  PubMed  PubMed Central  Google Scholar 

African Union, Africa Centres for Disease Control. COVID-19 vaccination. Africa CDC Vaccine Dashboard. Available from: https://africacdc.org/covid-19-vaccination/ [accessed 26 November 2022.

Alhossan A, Alsaran AK, Almahmudi AH, Aljohani ZS, Albishi MR, Almutairi AK (2022) Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis. Vaccines 10:2089

Article  PubMed  PubMed Central  Google Scholar 

Alqatari S, Ismail M, Hasan M, Bukhari R, Al Argan R, Alwaheed A et al (2023) Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A single-centre study. Infect Drug Resist 16:1263–1278

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baden LR, El Sahly HM, Essink B et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403–416

Article  PubMed  CAS  Google Scholar 

Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE et al (2021) Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open 4:e2140364.35,36

Article  Google Scholar 

Burkina Faso - COVID 19 Rapport de situation - Burkina Faso Open Data. Disponible sur: https://burkinafaso.opendataforafrica.org/jovpdge/burkina-faso-covid-19-rapport-de-situation.

Calina D, Docea AO, Petrakis D et al (2020) Towards effective COVID-19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med 46(1):3–16

Article  PubMed  PubMed Central  CAS  Google Scholar 

Castillo RA, Castrillo JCM (2022) Neurological manifestations associated with the COVID-19 vaccine. Neurologia (Engl Ed) 40(1):66–76

Google Scholar 

Chatterjee A, Chakravarty A (2023) Neurological complications following COVID19 vaccination. Curr Neurol Neurosci Rep 23:1–14

Article  PubMed  Google Scholar 

Cheung ECL, Leung MTY, Chen K, Wan EYF, Li X, Lai FTT et al (2023) Risk of adverse events and delirium after COVID-19 vaccination in patients living with dementia. J Am Med Dir Assoc 24:892

Article  PubMed  PubMed Central  Google Scholar 

Chileshe M, Mupeta G, Kasanga M, Mfune RL, Mudenda S, Biemba M, Shimaponda-Mataa NM, Sinkala M, Daka V (2021) Prevalence of adverse events post-COVID-19 vaccination amongst the adult Zambian population. J Biomed Res Environ Sci 2(12):1315–1321

Article  Google Scholar 

Dias L, Soares-Dos-Reis R, Meira J et al (2021) Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis 30:105906

Article  PubMed  PubMed Central  Google Scholar 

Doroftei B, Ciobica A, Ilie OD, Maftei R, Ilea C (2021) Discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics 11:579

Article  PubMed  PubMed Central  CAS  Google Scholar 

Douma B, Anis H, Jemai K, Asma N, Salma N, Amor SB (2022) Les manifestations neurologiques post-vaccination Covid-19: conséquence ou coïncidence? Rev Neurol (Paris) 178:S71

Article  Google Scholar 

Farhat M et al (2022) Study of the side effects of Pfizer and Oxford COVID-19 vaccines in the eastern province of Saudi Arabia. Int J Gen Med. https://doi.org/10.2147/IJGM.S379204

Article  PubMed  PubMed Central  Google Scholar 

Finsterer J (2022) Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand 145:5–9

Article  PubMed  CAS  Google Scholar 

Funk CD, Laferrière C, Ardakani A (2021) Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond: an early 2021 perspective. Viruses 13(3):418

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ganesan S, Al Ketbi LMB, Al Kaabi N, Al Mansoori M, Al Maskari NN, Al Shamsi MS et al (2022) Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study. Front Public Health 10:876336

Article  PubMed  PubMed Central  Google Scholar 

García-Grimshaw M, Ceballos-Liceaga SE, Hernández-Vanegas LE, Núñez I, Hernández-Valdivia N, Carrillo-García DA et al (2021) Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin Immunol 229:108786

Article  PubMed  PubMed Central  Google Scholar 

Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T et al (2021) First month of COVID-19 vaccine safety monitoring - United States. MMWR Morb Mortal Wkly Rep 70(8):283–288

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goss AL, Samudralwar RD, Das RR et al (2021) ANA Investigates: neurological complications of COVID-19 vaccines. Ann Neurol 89:856–885

Article  PubMed  PubMed Central  CAS  Google Scholar 

Han Q, Zheng B, Abakoumkin G, Leander NP, Stroebe W (2022) Why some people do not get vaccinated against COVID-19: social-cognitive determinants of vaccination behavior. Appl Psychol Health Well-Being 15:825–845

Article  PubMed  Google Scholar 

Harry AM, Edet CK, Ekanem NE, Kemdirim CJ, Uduak AE (2022) Adverse events following COVID-19 vaccination in Rivers State, Nigeria: a cross-sectional study. Niger Postgrad Med J 29(2):89–95

Article  PubMed  Google Scholar 

Hoffmann MA, Wieler HJ, Enders P, Buchholz HG, Plachter B (2021) Age- and Sex-Graded Data Evaluation of Vaccination Reactions after Initial Injection of the BNT162b2 mRNA Vaccine in a Local Vaccination Center in Germany. Vaccines 9(8):911

Article  PubMed  PubMed Central  CAS  Google Scholar 

Konu YR, Gbeasor-Komlanvi FA, Yerima M, Sadio AJ, Tchankoni MK, Zida Compaore WI et al (2021) Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archiv Public Health 79:1–9

Article  Google Scholar 

Moukafih B, Belaroussi L, Achour S, Kartouti AE (2024) Side effects reported by Moroccan medical students who received COVID-19 vaccines. Curr Drug Saf 19(2):268–276

Article  PubMed  CAS  Google Scholar 

Nguyen SV, Nguyen BT, Duong HNV, Lenh PT, Tran KT, Tran HM et al (2023) Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam. Hum Vaccin Immunother 19(1):2176066

Article  PubMed  PubMed Central  Google Scholar 

Onyango J, Mukunya D, Napyo A, Nantale R, Makoko BT, Matovu JK et al (2022) Side-effects following Oxford/AstraZeneca COVID-19 vaccine in Tororo district, eastern Uganda: a cross-sectional study. Int J Environ Res Public Health 19(22):15303

Article  PubMed  PubMed Central  Google Scholar 

Parida SP, Sahu DP, Singh AK et al (2022) Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol 94:2453–2459

Article  PubMed  PubMed Central  CAS  Google Scholar 

Polack FP, Thomas SJ, Kitchin N et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603–2615

Article  PubMed  CAS  Google Scholar 

Ramasamy MN, Minassian AM, Ewer KJ et al (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 396:1979–1993

Article  PubMed  PubMed Central  CAS  Google Scholar 

Riyyan M, Sajid S, Hotwani S, Chania HA, Shaikh MS, Sadiq Y et al (2022) Multimorbidity and Its Effect on Self-Reported Adverse Effects Following COVID-19 Vaccination. Cureus 14(12):e33139

PubMed  PubMed Central  Google Scholar 

Salsone M, Signorelli C, Oldani A, Alberti VF, Castronovo V, Mazzitelli S et al (2023) NEURO-COVAX: an Italian population-based study of neurological complications after COVID-19 vaccinations. Vaccines 11(10):1621